In the work of Yuan et al., the hydroxamic acid derivatives of NSC 319745 showed inhibition of DNMT1, HDAC1, and HDAC6, plus cytotoxicity activity against human cancer cells [47]. The gene discussed is HDAC1; the disease is cancer.